FDA Finds New Data Linking Bad Heparin To China

Law360, New York (April 22, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration has found new evidence linking deaths and allergic reactions to a man-made contaminant that had been introduced in the blood thinner heparin during production in China.

Dr. Janet Woodcock, the director of the FDA's Center for Drug Evaluation and Research, said on Monday that a contaminant in the heparin batches was traced to 12 different Chinese companies. The batches were shipped to 11 nations.

The FDA pointed to over-sulfated chondroitin sulfate as the root cause of the adverse reactions. The...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.